WGS
The table below shows GeneDx Holdings Corp.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $93.92M | $95.97M | $74.12M | $99.70M | $57.89M | $56.08M |
| Short-term investments | $76.76M | $59.11M | $60.44M | $59.46M | $58.57M | $50.78M |
| Receivables | $76.93M | $60.94M | $48.03M | $45.98M | - | - |
| Inventory | $12.24M | $10.57M | $11.93M | $12.66M | $10.77M | $10.32M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $270.63M |
| $237.58M |
| $204.84M |
| $225.82M |
| $186.01M |
| $162.17M |
| Property, plant & equipment | $50.13M | - | - | - | - | - |
| Goodwill | $1.64M | $12.80M | $12.93M | - | - | - |
| Total assets | $506.30M | $493.90M | $463.86M | $446.43M | $408.84M | $389.10M |
| Accounts payable | $11.17M | $2.63M | $3.52M | $15.86M | $9.02M | $8.13M |
| Total current liabilities | $87.64M | $87.62M | $71.41M | $69.54M | $77.34M | $68.27M |
| Long-term debt | $96.73M | $51.58M | $51.68M | $51.79M | $52.03M | $52.16M |
| Total liabilities | $252.18M | $201.64M | $186.73M | $189.03M | $204.34M | $195.06M |
| Retained earnings | -$1.44B | -$1.36B | -$1.35B | -$1.36B | -$1.36B | -$1.35B |
| Total equity | $254.12M | $292.26M | $277.13M | $257.40M | $204.50M | $194.04M |